Nextage Therapeutics Ownership

Stocks . Israel . 
Stock . Nextage Therapeutics
MCTC Stock  ILA 78.00  3.00  4.00%   
Nextage Therapeutics holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months.
Some institutional investors establish a significant position in stocks such as Nextage Therapeutics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Nextage Therapeutics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nextage Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Nextage Stock Ownership Analysis

About 22.0% of the company outstanding shares are owned by corporate insiders. The book value of Nextage Therapeutics was now reported as 0.9. The company recorded a loss per share of 0.24. Nextage Therapeutics last dividend was issued on the 9th of June 2003. The entity had 1:20 split on the 12th of April 2020. Micromedic Technologies Ltd develops and commercializes in-vitro cancer diagnostic products and solutions worldwide. Further, the company provides diagnostic solutions for multiple cancer diagnostic applications. MICROMEDIC TECHNOL operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. To find out more about Nextage Therapeutics contact Meir Yoeli at 972 73 2753450 or learn more at http://www.m-medic.com.

Nextage Therapeutics Outstanding Bonds

Nextage Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nextage Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nextage bonds can be classified according to their maturity, which is the date when Nextage Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Boeing Co 2196 Corp Bond
US097023DG73		View
MPLX LP 4125 Corp Bond
US55336VAK61		View
MPLX LP 52 Corp Bond
US55336VAL45		View
International Game Technology Corp Bond
US460599AD57		View
BNP Paribas FRN Corp Bond
USF1R15XK367		View
Morgan Stanley 3591 Corp Bond
US61744YAK47		View
MGM Resorts International Corp Bond
US552953CD18		View
Valero Energy Partners Corp Bond
US91914JAA07		View

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FFord Motor
GMGeneral Motors
SSentinelOne

Other Information on Investing in Nextage Stock

Nextage Therapeutics financial ratios help investors to determine whether Nextage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nextage with respect to the benefits of owning Nextage Therapeutics security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY